Skip to main content

Zevra Therapeutics, Inc 10-Q for FY2020 Q3

Zevra Therapeutics, Inc. (ZVRA)

10-Q 2020-10-30 For: 2020-09-30
View Original
Added on April 10, 2026

About this 10-Q

Zevra Therapeutics, Inc filed this 10-Q on October 30, 2020, covering the quarter ended September 30, 2020 (FY2020 Q3).

Headline figures

Quarter ended September 30, 2020, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$1.93M
down 83.2% from $11.46M a year earlier
Net loss
$3.01M
compared with net income of $3.06M a year earlier
Diluted EPS
-$0.04
compared with $0.06 a year earlier